WILMINGTON – The biopharmaceutical startup NiKang Therapeutics announced Wednesday that it has signed a second clinical trial collaboration with a biopharma firm for its small-molecule therapy drug in about a […]
© 2024 Delaware Business Times
Important notice for access to your Delaware Business Times “Insider” content
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.